Tharimmune makes $540M bet on Canton Coin in crypto treasury push
Biotech company Tharimmune raised $540 million to fund a crypto treasury strategy centered on acquiring Canton Coin (CC).Summary
Biotech firm Tharimmune has secured $540 million in private funding to launch a cryptocurrency treasury strategy, which includes purchasing Canton Coin (CC), the native token of the Canton Network. This private offering was led by DRW and Liberty City Ventures, with participation from major investors like ARK Invest and Polychain Capital. The funds will also support general operations and allow Tharimmune to expand its role in the Canton ecosystem, including becoming a Super Validator to strengthen network performance. Tharimmune, which develops therapeutics for inflammation and immunology disorders, saw its stock rise following the announcement. The Canton Network is an enterprise blockchain backed by major financial institutions, and this move highlights the accelerating trend of traditional finance integrating on-chain assets.
(Source：Cointelegraph)